SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.490+3.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (110)8/4/1997 7:58:00 AM
From: David   of 645
 
V1, your posts are much better than Brad's.

The positives of AVIR are in very details. However, all those positives were there before the clinical trial announced and have built into the price. I don't need to point out that some those points had been criticized, such as market size and cost benifit of nasal delivery.

For the negtives, you seems forgot that over 30% total shares of AVIR has been filed in 144 form by insiders in June and July only. They knew much more about the company's future than you and me. Why should investors get in at such high price when insiders take money off the table? Mr Ni asked Brad gives a same biotech company with the great potential had such huge insiders sell in such short time but he did not do so. I wish you could tell us something in this aspect.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News